These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26721885)
1. Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance. Park AC; Huang G; Jankowska-Gan E; Massoudi D; Kernien JF; Vignali DA; Sullivan JA; Wilkes DS; Burlingham WJ; Greenspan DS J Biol Chem; 2016 Feb; 291(7):3359-70. PubMed ID: 26721885 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis. Dart ML; Jankowska-Gan E; Huang G; Roenneburg DA; Keller MR; Torrealba JR; Rhoads A; Kim B; Bobadilla JL; Haynes LD; Wilkes DS; Burlingham WJ; Greenspan DS Circ Res; 2010 Oct; 107(9):1106-16. PubMed ID: 20814021 [TBL] [Abstract][Full Text] [Related]
3. Type V collagen-induced nasal tolerance prevents lung damage in an experimental model: new evidence of autoimmunity to collagen V in COPD. Robertoni FSZ; Velosa APP; Oliveira LM; de Almeida FM; da Silveira LKR; Queiroz ZAJ; Lobo TM; Contini VE; Baldavira CM; Carrasco S; Fernezlian SM; Sato MN; Capelozzi VL; Lopes FDTQDS; Teodoro WPR Front Immunol; 2024; 15():1444622. PubMed ID: 39301030 [TBL] [Abstract][Full Text] [Related]
4. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis. Thota LN; Ponnusamy T; Lu X; Mundkur L Cardiovasc Drugs Ther; 2019 Aug; 33(4):385-398. PubMed ID: 31332656 [TBL] [Abstract][Full Text] [Related]
6. Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice. Bauer RC; Tohyama J; Cui J; Cheng L; Yang J; Zhang X; Ou K; Paschos GK; Zheng XL; Parmacek MS; Rader DJ; Reilly MP Circulation; 2015 Mar; 131(13):1202-1213. PubMed ID: 25712206 [TBL] [Abstract][Full Text] [Related]
7. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474 [TBL] [Abstract][Full Text] [Related]
8. Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis. Hasselberg A; Schön K; Tarkowski A; Lycke N Arthritis Rheum; 2009 Jun; 60(6):1672-82. PubMed ID: 19479868 [TBL] [Abstract][Full Text] [Related]
9. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene. Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818 [TBL] [Abstract][Full Text] [Related]
11. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor. Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice. Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052 [TBL] [Abstract][Full Text] [Related]
13. Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability. Liu J; Lin J; He S; Wu C; Wang B; Liu J; Duan Y; Liu T; Shan S; Yang K; Dong N; Ji Q; Huang K; Li D Cell Physiol Biochem; 2018; 45(3):1034-1050. PubMed ID: 29439249 [TBL] [Abstract][Full Text] [Related]
14. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638 [TBL] [Abstract][Full Text] [Related]
15. Collagen V nasal tolerance in experimental model of systemic sclerosis. Velosa AP; Teodoro WR; de Oliveira CC; Dos Santos Filho A; Moutinho RF; Santos AG; Vendramini MB; Bueno C; Parra ER; Capelozzi VL; Yoshinari NH Arch Dermatol Res; 2007 Jul; 299(4):177-89. PubMed ID: 17297604 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice. Hirase T; Hara H; Miyazaki Y; Ide N; Nishimoto-Hazuku A; Fujimoto H; Saris CJ; Yoshida H; Node K Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H420-9. PubMed ID: 23729211 [TBL] [Abstract][Full Text] [Related]
17. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice. Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908 [TBL] [Abstract][Full Text] [Related]
18. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice. Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693 [TBL] [Abstract][Full Text] [Related]
19. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637 [TBL] [Abstract][Full Text] [Related]
20. Melanocortin overexpression limits diet-induced inflammation and atherosclerosis in LDLR Nuutinen S; Ailanen L; Savontaus E; Rinne P J Endocrinol; 2018 Mar; 236(3):111-123. PubMed ID: 29317531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]